| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/21/2011 | WO2011044746A1 Bamboo or wood vinegar solution, preparation method and use thereof |
| 04/21/2011 | WO2011044737A1 Use of cyclophosphamide for treating condyloma acuminata |
| 04/21/2011 | WO2011044736A1 Pharmaceutical composition for treating skin injury, preparation method of its ointment and use thereof |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2010138519A9 Use of adsorbent carbon microspheres for the treatment of pruritus |
| 04/21/2011 | WO2010135655A3 Human skin substitutes expressing il-12 |
| 04/21/2011 | WO2010135527A3 Elastin for soft tissue augmentation |
| 04/21/2011 | US20110092669 Synthesis of cyclosporin analogs |
| 04/21/2011 | US20110092599 Use of Treprostinil to treat neuropathic diabetic foot ulcers |
| 04/21/2011 | US20110092589 Treatment of Inflammatory Conditions and Diseases with Metal-Thiols |
| 04/21/2011 | US20110092584 Therapeutic use of quinonoid derivatives of cannabinoids |
| 04/21/2011 | US20110092571 Compositions and methods for sirna inhibition of icam-1 |
| 04/21/2011 | US20110092562 Method for wetting a powder containing benzoyl peroxide |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092530 Cyclopamine tartrate salt and uses thereof |
| 04/21/2011 | US20110092528 Piperidinyl compounds that selectively bind integrins |
| 04/21/2011 | US20110092522 Wound and Skin Care Procuts |
| 04/21/2011 | US20110092517 Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related Diseases |
| 04/21/2011 | US20110092505 Organic compounds |
| 04/21/2011 | US20110092502 Diaminothiazoles useful as axl inhibitors |
| 04/21/2011 | US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents |
| 04/21/2011 | US20110092478 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092472 Enzymatic process for obtaining 17 alpha- monoesters of cortexolone and/or its 9,11- dehydroderivatives |
| 04/21/2011 | US20110092463 Combination for use in the treatment of inflammatory disorders |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092439 Method of promoting wound healing |
| 04/21/2011 | US20110092437 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/21/2011 | US20110092431 Skin aging-inhibiting peptide |
| 04/21/2011 | US20110092427 Polypeptide and pharmaceutical composition containing the polypeptide |
| 04/21/2011 | US20110092422 Elastin based growth factor delivery platform for wound healing and regeneration |
| 04/21/2011 | US20110092421 Methods for generating new hair follicles, treating baldness, and hair removal |
| 04/21/2011 | US20110091586 Compositions containing amines and use thereof |
| 04/21/2011 | US20110091584 Lymphatic vessel stabilizer |
| 04/21/2011 | US20110091578 Method of stimulating tissue healing |
| 04/21/2011 | US20110091576 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells |
| 04/21/2011 | US20110091572 Acne treatment compositions comprising nanosilver and uses |
| 04/21/2011 | US20110091565 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| 04/21/2011 | US20110091564 Injectable hollow tissue filler |
| 04/21/2011 | US20110091557 Composite material |
| 04/21/2011 | US20110091552 Use of Bcl Inhibitors for the Treatment of Scarring Caused By Cutaneous Wounds, Burns and Abrasions |
| 04/21/2011 | US20110091551 Wound covering comprising octenidine dihydrochloride for use in the antisepsis of catheter insertion points |
| 04/21/2011 | US20110091550 Methods for Promoting the Revascularization and Reenervation of CNS Lesions |
| 04/21/2011 | US20110091548 Use of a matrix for orally administering sustained release magnesium, and composition containing said matrix |
| 04/21/2011 | US20110091538 Polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 04/21/2011 | US20110091531 Cooling Composition |
| 04/21/2011 | US20110091527 Compositions and methods for reducing scar formation in wound healing |
| 04/21/2011 | US20110091503 Therapeutic composition with a botulinum neurotoxin |
| 04/21/2011 | US20110091485 Modulation of cell junctions |
| 04/21/2011 | US20110091483 Canine Anti-CD20 Antibodies |
| 04/21/2011 | US20110091475 Anti-Human Interleukin-20 Antibodies |
| 04/21/2011 | US20110091472 Compositions for treating psoriasis |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091465 Polypeptides |
| 04/21/2011 | US20110091463 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | US20110091453 Methods of administering/dosing cd2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory diseases |
| 04/21/2011 | US20110091449 Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies |
| 04/21/2011 | US20110091443 Heparin-conjugated fibrin gel and method and kit for preparing same |
| 04/21/2011 | US20110091406 Composition and method for protecting labile active components during high temperature drying |
| 04/21/2011 | US20110091405 Composition and methods for promoting lush hair growth |
| 04/21/2011 | US20110091403 Oligosaccharide aldonic acids and their topical use |
| 04/21/2011 | US20110091387 Methods and compositions for reducing skin damage |
| 04/21/2011 | US20110091385 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 04/21/2011 | US20110091379 Method for treating tumors and their metastases |
| 04/21/2011 | US20110091372 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 04/21/2011 | DE102009048044A1 Verwendung von Magnolol oder Honokiol als antibakterielle, antimycotische, antiparasitäre oder antivirale Wirkstoffe Use of magnolol and honokiol as antibacterial, antifungal, antiparasitic and antiviral agents |
| 04/21/2011 | DE102009035109A1 Wundheilzusammensetzung Wound healing composition |
| 04/21/2011 | DE102005057292B4 Haarnährstoffschlucktablette Hair nutrient absorption tablet |
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/20/2011 | EP2311944A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311869A1 Use of mammalian cytokine; related reagents |
| 04/20/2011 | EP2311849A1 Specific binding agents of human angiopoietin-2 |
| 04/20/2011 | EP2311847A1 Composition containing stable vitamin B6 derivative |
| 04/20/2011 | EP2311829A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311808A1 Substituted alkylamine derivatives and methods of use |
| 04/20/2011 | EP2311494A1 Histone modification inhibitor specific to target gene |
| 04/20/2011 | EP2311485A1 Thymosin beta 4 promotes wound repair |
| 04/20/2011 | EP2311469A2 Methods and compositions for tissue regeneration |
| 04/20/2011 | EP2311466A2 Antimicrobial compounds and methods for their use |
| 04/20/2011 | EP2311456A1 Wound and mucous membrane antiseptic based on bispyridiniumalkanes |
| 04/20/2011 | EP2311454A2 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
| 04/20/2011 | EP2311453A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 04/20/2011 | EP2311452A1 Topical composition comprising n-acetyl glucosamine |
| 04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310052A2 Acne treatment compositions comprising nanosilver and uses |
| 04/20/2011 | EP2310041A2 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 04/20/2011 | EP2310031A1 Combination of a tiliroside and a peptide |
| 04/20/2011 | EP2310022A1 Topical medicament |
| 04/20/2011 | EP2309981A2 Dermatological composition that can be used in particular for the care and prevention of eschars |
| 04/20/2011 | EP2309976A1 Cosmetic compositions comprising asteroidea body fluid and methods of use thereof |
| 04/20/2011 | EP1449534B1 Ganoderma atrum extract as matrix metalloprotease inhibitor |
| 04/20/2011 | EP1385993B1 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 04/20/2011 | CN1981845B Chinese-medicinal composition, its production and use |
| 04/20/2011 | CN102027106A Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026663A Controlled release of active agents from oleosomes |
| 04/20/2011 | CN102026662A Stabilized oleosome preparations and methods of making them |